乌鸦传媒

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 乌鸦传媒, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

A senior man sleeps in a hospital bed.

<乌鸦传媒>Can the Death Rattle Be Silenced?

Randomized trial says yes, but results may be challenging to put into practice

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>European CVD Prevention Guide Leans on Age Stratification

Update has new risk assessment score but goes easy on blood pressure

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Lower BP Targets Again Affirmed in Major Trial

STEP trial from China shows major benefits in older population

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Nonsteroidal MRA Drug Cuts Risks in Earlier Diabetic Kidney Disease

Urine screening urged after trial shows benefit of treating cases with preserved kidney function

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Add FFR to Diagnostic Angiography? Don't Bother

RIPCORD2 gives resounding "no" on all counts

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>His Bundle Pacing Stars in European Guidelines

Revised edition could signal coming U.S. recommendations too

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS

APAF-CRT trial reinforces the case for expanded CRT indication

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Milder Heart Failure Might Benefit From Implantable Monitors

Randomized trial signals benefit, albeit hampered by the pandemic

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Loop Recorder Often Finds Major Arrhythmias in Risky Group Post MI

Serious events common in group with an LVEF of 36% to 50% and autonomic dysfunction

ESC over a perspective view of a heartbeat on a vital signs monitor.

<乌鸦传媒>Kidney Disease No Barrier to Effient Benefit in ACS

Trial analysis supports superiority over ticagrelor regardless of eGFR

鈥�

34

鈥�